322 related articles for article (PubMed ID: 8438266)
1. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
Fangmann J; Dalchau R; Fabre JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
[No Abstract] [Full Text] [Related]
2. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
[No Abstract] [Full Text] [Related]
3. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
Benham AM; Fabre JW
Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
[No Abstract] [Full Text] [Related]
4. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
[No Abstract] [Full Text] [Related]
5. CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts.
Morton AL; Bolton EM; Lawes CM; Porteous C; Bradley JA
Transplant Proc; 1993 Feb; 25(1 Pt 1):102-3. PubMed ID: 8438240
[No Abstract] [Full Text] [Related]
6. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
Fangmann J; Dalchau R; Fabre JW
J Exp Med; 1992 Jun; 175(6):1521-9. PubMed ID: 1588278
[TBL] [Abstract][Full Text] [Related]
7. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation.
Matsumiya G; Shirakura R; Miyagawa S; Nakata S; Nakano S; Kinoshita T; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 1):402-4. PubMed ID: 8438354
[No Abstract] [Full Text] [Related]
9. Induction of acute rejection by indirect recognition of donor MHC antigens.
Terness P; Dufter C; Otto G; Opelz G
Transplant Proc; 1995 Feb; 27(1):457-8. PubMed ID: 7879060
[No Abstract] [Full Text] [Related]
10. Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo.
Fukuzawa M; Okada A; Shearer GM
Transplant Proc; 1991 Dec; 23(6):2945-7. PubMed ID: 1721321
[No Abstract] [Full Text] [Related]
11. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection.
Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
Eur J Immunol; 1992 Jun; 22(6):1525-30. PubMed ID: 1601039
[TBL] [Abstract][Full Text] [Related]
13. The role of CD4+ and CD8+ T cells in rejection of class I MHC disparate renal allografts.
Bradley JA; Gracie JA; Porteous C; Bolton EM
Transplant Proc; 1991 Feb; 23(1 Pt 1):266-7. PubMed ID: 1899304
[No Abstract] [Full Text] [Related]
14. Xenograft rejection of class I-expressing transgenic skin is CD4-dependent and CD8-independent.
Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
Transplant Proc; 1990 Oct; 22(5):2335-6. PubMed ID: 2120817
[TBL] [Abstract][Full Text] [Related]
15. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
16. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
17. Contribution of CD4+ cells to allorejection across a class I major histocompatibility complex barrier in congeneic rats.
Stepkowski SM; Goto S; Wiggins J; Christopher J; Kahan BD
Transplant Proc; 1991 Feb; 23(1 Pt 1):172-3. PubMed ID: 1990506
[No Abstract] [Full Text] [Related]
18. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
Krieger NR; Fathman CG
J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
[No Abstract] [Full Text] [Related]
19. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
20. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
